Stonebridge Capital Advisors’s CME Group CME Stock Holding History

Stonebridge Capital Advisors’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-222	Closed	-$44.5K	–	334
2023 Q3	$44.5K	Hold	222	–	–	﹤0.01%	379
2023 Q2	$41.2K	Sell	222 -41	-16%	-$7.58K	﹤0.01%	398
2023 Q1	$50.4K	Buy	263 +41	+18%	+$7.41K	0.01%	363
2022 Q4	$37.4K	Buy	222 +193	+666%	+$33.5K	﹤0.01%	397
2022 Q3	$5K	Buy	29 +13	+81%	+$2.57K	﹤0.01%	673
2022 Q2	$3K	Hold	16	–	–	﹤0.01%	766
2022 Q1	$4K	Hold	16	–	–	﹤0.01%	795
2021 Q4	$4K	Buy	+16	New	+$3.52K	﹤0.01%	764
2020 Q1	–	Sell	-21	Closed	-$4K	–	787
2019 Q4	$4K	Buy	+21	New	+$4.31K	﹤0.01%	668
2019 Q3	–	Sell	-60	Closed	-$12K	–	875
2019 Q2	$12K	Buy	+60	New	+$11.1K	﹤0.01%	540

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Stonebridge Capital Advisors's CME Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of CME Group (CME) in Q4 2023, closing a stake of 222 shares — an estimated $44.5K sold.

Stonebridge Capital Advisors first reported a position in CME in Q2 2019 and held it in 10 quarters. The position peaked at $50.4K in Q1 2023. 1,361 funds tracked by Wall St. Rank hold CME as of Q4 2023.

Stonebridge Capital Advisors reported no remaining CME Group position as of Q4 2023 after selling out during the quarter.
Stonebridge Capital Advisors sold 222 CME Group shares in Q4 2023, an estimated $44.5K.
Stonebridge Capital Advisors first reported a position in CME Group in Q2 2019 and held it in 10 quarters.
Stonebridge Capital Advisors's CME Group position peaked at $50.4K in Q1 2023.
1,361 funds tracked by Wall St. Rank held CME Group as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.